Star Combo Pharma Ltd (AU:S66) — Market Cap & Net Worth
Market Cap & Net Worth: Star Combo Pharma Ltd (S66)
Star Combo Pharma Ltd (AU:S66) has a market capitalization of $13.38 Million (AU$18.91 Million) as of September 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #26410 globally and #1198 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Star Combo Pharma Ltd's stock price AU$0.14 by its total outstanding shares 135082901 (135.08 Million). Also see S66 total asset value for a full breakdown of the balance sheet.
Star Combo Pharma Ltd Market Cap History: 2018 to 2026
Star Combo Pharma Ltd's market capitalization history from 2018 to 2026. Data shows change from $52.75 Million to $13.38 Million (-18.49% CAGR). Also see how efficiently does Star Combo Pharma Ltd generate cash for how efficiently the company converts equity into cash flow.
Star Combo Pharma Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Star Combo Pharma Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check S66 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.89x
Star Combo Pharma Ltd's market cap is 0.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.73x
Star Combo Pharma Ltd's market cap is 4.73 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $52.75 Million | $10.75 Million | -$1.97 Million | 4.91x | N/A |
| 2019 | $45.29 Million | $21.41 Million | -$1.73 Million | 2.12x | N/A |
| 2020 | $30.81 Million | $38.84 Million | -$348.69K | 0.79x | N/A |
| 2021 | $23.81 Million | $26.72 Million | -$7.88 Million | 0.89x | N/A |
| 2022 | $14.00 Million | $22.88 Million | -$696.35K | 0.61x | N/A |
| 2023 | $13.53 Million | $24.70 Million | -$4.00 Million | 0.55x | N/A |
| 2024 | $13.38 Million | $26.02 Million | $747.33K | 0.51x | 17.91x |
| 2025 | $24.85 Million | $27.81 Million | $5.25 Million | 0.89x | 4.73x |
Competitor Companies of S66 by Market Capitalization
Companies near Star Combo Pharma Ltd in the global market cap rankings as of September 20, 2026. Review how tangible is Star Combo Pharma Ltd's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Star Combo Pharma Ltd by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #49 globally with a market cap of $342.07 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #99 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #100 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #207 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #49 | Procter & Gamble Company | NYSE:PG | $342.07 Billion | $146.39 |
| #99 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #100 | LOréal S.A. | PA:OR | $204.16 Billion | €376.05 |
| #207 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Star Combo Pharma Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Star Combo Pharma Ltd's market cap moved from $52.75 Million to $ 13.38 Million, with a yearly change of -18.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$13.38 Million | -46.15% |
| 2025 | AU$24.85 Million | +85.71% |
| 2024 | AU$13.38 Million | -1.13% |
| 2023 | AU$13.53 Million | -3.34% |
| 2022 | AU$14.00 Million | -41.19% |
| 2021 | AU$23.81 Million | -22.74% |
| 2020 | AU$30.81 Million | -31.95% |
| 2019 | AU$45.29 Million | -14.15% |
| 2018 | AU$52.75 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Star Combo Pharma Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.38 Million USD |
| MoneyControl | $13.38 Million USD |
| MarketWatch | $13.38 Million USD |
| marketcap.company | $13.38 Million USD |
| Reuters | $13.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more